MicroRNA-34a: the bad guy in age-related vascular diseases

被引:63
|
作者
Raucci, Angela [1 ]
Macri, Federica [1 ]
Castiglione, Stefania [1 ]
Badi, Ileana [1 ,3 ]
Vinci, Maria Cristina [2 ]
Zuccolo, Estella [1 ]
机构
[1] Ctr Cardiol Monzino IRCCS, Expt Cardiooncol & Cardiovasc Aging Unit, Via C Parea 4, I-20138 Milan, Italy
[2] Ctr Cardiol Monzino IRCCS, Unit Vasc Biol & Regenerat Med, Milan, Italy
[3] Univ Oxford, Div Cardiovasc Med, Radcliffe Dept Med, Oxford, England
关键词
Senescence; Inflammaging; microRNA; Vascular calcification; Atherosclerosis; Diabetes; SMOOTH-MUSCLE-CELLS; CORONARY-ARTERY-DISEASE; MIR-34A EXPRESSION; TUMOR-SUPPRESSOR; REPLICATIVE SENESCENCE; PULMONARY-HYPERTENSION; ELEVATED MICRORNA-34A; EPIGENETIC REGULATION; DEPENDENT REGULATION; MONONUCLEAR-CELLS;
D O I
10.1007/s00018-021-03979-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The age-related vasculature alteration is the prominent risk factor for vascular diseases (VD), namely, atherosclerosis, abdominal aortic aneurysm, vascular calcification (VC) and pulmonary arterial hypertension (PAH). The chronic sterile low-grade inflammation state, alias inflammaging, characterizes elderly people and participates in VD development. MicroRNA34-a (miR-34a) is emerging as an important mediator of inflammaging and VD. miR-34a increases with aging in vessels and induces senescence and the acquisition of the senescence-associated secretory phenotype (SASP) in vascular smooth muscle (VSMCs) and endothelial (ECs) cells. Similarly, other VD risk factors, including dyslipidemia, hyperglycemia and hypertension, modify miR-34a expression to promote vascular senescence and inflammation. miR-34a upregulation causes endothelial dysfunction by affecting ECs nitric oxide bioavailability, adhesion molecules expression and inflammatory cells recruitment. miR-34a-induced senescence facilitates VSMCs osteoblastic switch and VC development in hyperphosphatemia conditions. Conversely, atherogenic and hypoxic stimuli downregulate miR-34a levels and promote VSMCs proliferation and migration during atherosclerosis and PAH. MiR34a genetic ablation or miR-34a inhibition by anti-miR-34a molecules in different experimental models of VD reduce vascular inflammation, senescence and apoptosis through sirtuin 1 Notch1, and B-cell lymphoma 2 modulation. Notably, pleiotropic drugs, like statins, liraglutide and metformin, affect miR-34a expression. Finally, human studies report that miR-34a levels associate to atherosclerosis and diabetes and correlate with inflammatory factors during aging. Herein, we comprehensively review the current knowledge about miR-34a-dependent molecular and cellular mechanisms activated by VD risk factors and highlight the diagnostic and therapeutic potential of modulating its expression in order to reduce inflammaging and VD burn and extend healthy lifespan.
引用
收藏
页码:7355 / 7378
页数:24
相关论文
共 50 条
  • [31] Medical bioremediation of age-related diseases
    Mathieu, Jacques M.
    Schloendorn, John
    Rittmann, Bruce E.
    Alvarez, Pedro J. J.
    MICROBIAL CELL FACTORIES, 2009, 8
  • [32] MicroRNA-34a induces transdifferentiation of glioma stem cells into vascular endothelial cells by targeting Notch pathway
    Jin, Zaishun
    Zhan, Tao
    Tao, Jing
    Xu, Biao
    Zheng, Huizhe
    Cheng, Yongxia
    Yan, Bin
    Wang, Hongwei
    Lu, Guoqiang
    Lin, Ying
    Guo, Sufen
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2017, 81 (10) : 1899 - 1907
  • [33] Autophagy as an emerging therapeutic target for age-related vascular pathologies
    De Munck, Dorien G.
    De Meyer, Guido R. Y.
    Martinet, Wim
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2020, 24 (02) : 131 - 145
  • [34] Caveolin-1, cellular senescence and age-related diseases
    Zou, Huafei
    Stoppani, Elena
    Volonte, Daniela
    Galbiati, Ferruccio
    MECHANISMS OF AGEING AND DEVELOPMENT, 2011, 132 (11-12) : 533 - 542
  • [35] Senotherapeutics: Targeting senescent cells for the main age-related diseases
    Boccardi, Virginia
    Mecocci, Patrizia
    MECHANISMS OF AGEING AND DEVELOPMENT, 2021, 197
  • [36] Age-related vascular stiffening: causes and consequences
    Kohn, Julie C.
    Lampi, Marsha C.
    Reinhart-King, Cynthia A.
    FRONTIERS IN GENETICS, 2015, 6
  • [37] Senescent T Cells in Age-Related Diseases
    Yu, Pei-Jie
    Zhou, Mei
    Liu, Yan
    Du, Jie
    AGING AND DISEASE, 2025, 16 (01): : 321 - 344
  • [38] Recent Advances in Senolysis for Age-Related Diseases
    Aratani, Sae
    Nakanishi, Makoto
    PHYSIOLOGY, 2023, 38 (05) : 205 - 216
  • [39] Noncoding RNAs in age-related cardiovascular diseases
    Jusic, Amela
    Thomas, Pinar Buket
    Wettinger, Stephanie Bezzina
    Dogan, Soner
    Farrugia, Rosienne
    Gaetano, Carlo
    Tuna, Bilge Guvenc
    Pinet, Florence
    Robinson, Emma L.
    Tual-Chalot, Simon
    Stellos, Konstantinos
    Devaux, Yvan
    AGEING RESEARCH REVIEWS, 2022, 77
  • [40] Age-related bone diseases: Role of inflammaging
    Bi, Jiaming
    Zhang, Caimei
    Lu, Caihong
    Mo, Chuzi
    Zeng, Jiawei
    Yao, Mingyan
    Jia, Bo
    Liu, Zhongjun
    Yuan, Peiyan
    Xu, Shuaimei
    JOURNAL OF AUTOIMMUNITY, 2024, 143